![Breakthroughs that change patients’ lives]({"type":"image" , "src" : "/sda/112393/JournalAd-TACD-Pfizer-Leaderboard.jpg"})
References
- Mannting F, Morgan-Mannting MG. Gated SPECT with technetium-99m-sestamibi for assessment of myocardial per-fusion abnormalities. J Nucl Med 1993; 34: 601–8.
- Eisner RL, Schmarkey LS, Martin SE, Carey D, Worthy MA, Chu TH, Horowitz SF, Patterson RE. Defects on SPECT “perfusion” images can occur due to abnormal seg-mental contraction. J Nucl Med 1994; 35: 638–43.
- Chua T, Kiat H, Germano G, Maurer G, van Train K, Friedman J, Berman D. Gated technetium-99m-sestamibifor simultaneous assessment of stress myocardial perfusion, post-exercise regional ventricular function and myocardial viability. Correlation with echocardiography and rest thal-lium-201 scintigraphy. J Am Coll Cardiol 1994; 23: 1107–14.
- Williams K, Talon L. Reversible ischemia in severe stress technetium 99m-labelled Sestamibi perfusion defects assessed from gated single-photon emission tomographic polar map Fourier analysis. J Nucl Cardiol 1995; 2: 199–206.
- Christian TF, O’Connor MK, Glynn RB, Rogers PJ, Gibbons RJ. The influence of gating on measurements of myocardium at risk and infarct size during acute myocar-dial infarction by tomographic technetium 99m-labeled Sestamibi imaging. J Nucl Cardiol 1995; 2: 207–16.
- DePuey EG, Rozanski A. Using gated technetium-99m-sestamibi SPECT to characterize fixed myocardial defects as infarct or artifact. J Nucl Med 1995; 36: 952–55.
- Borges Neto S, Shaw LK. The added value of simultaneous myocardial perfusion and left ventricular function. Curr Opin Cardiol 1999; 14: 460–3.
- Beller GA, Ragosta M. Extent of myocardial viability in regions of left ventricular dysfunction by rest-redistribution thallium-201 imaging. A powerful predictor of outcome. J NucL Cardiol 1998; 5: 445–8.
- Sharir T, Berman DS, Lewin HC, Friedman JD, Cohen I, Miranda R, Agafitei RD, Germano G. Incremental prog-nostic value of post-stress left ventricular ejection fraction and volume by gated myocardial perfusion single photon emission computed tomography. Circulation 1999; 100 (Sep-tember 7): 1035–42.
- Cuocolo A, Petretta M, Nicolai E, Pace L, Bonaduce D, Salvatore M, Trimarco B. Successful coronary revasculariza-tion improves prognosis in patients with previous myocardial infarction and evidence of viable myocardium at thallium-201 imaging. Eur J Nucl Med 1998; 25: 60–8.
- Williams KA, Taillon LA. Left ventricular function in patients with coronary artery disease assessed by gated tomo-graphic myocardial perfusion images: comparison with assessment by contrast ventriculography and first-pass radionuclide angiography. J Am Coll Cardiol 1996; 27: 173–81.
- Germano G, Kiat H, Kavanagh PB, Moriel M, MazzantiM, Su HT. Automatic quantification of ejection fraction from gated myocardial perfusion SPECT. J Nucl Med 1995; 36: 2138–47.
- Germano G, Jacob E, Kiat H, Kavanagh P, Berman DS. Quantitative LVEF and qualitative regional function from gated thallium 201 perfusion SPECT. J Nucl Med 1997; 38: 749–54.
- Mazzanti M, Germano G, Kiat H, Friedman J, Berman DS. Fast technetium 99m-labelled Sestamibi gated single-photon emission computed tomography for evaluation of myocardial function. J Nucl Cardiol 1996; 3: 143–9.
- Bestetti A, Di Leo C, Alessi A, Triulzi A, Tagliabue L, Tarolo GL. Post-stress end-systolic left ventricular dilation: a marker of endocardial post-ischemic stunning. Nucl Medicine Com-munications 2001; 22: 685–93.
- Shark T, Germano G, Kang X, Lewin H, Miranda R, Cohen I. Prediction of myocardial infarction versus cardiac death by gated myocardial perfusion SPECT: Risk stratification by the amount of stress-induced ischemia and the post stress ejection fraction. J Nucl. Med 2001; 42: 831–7.
- Nanasato M, Ando A, Isobe S, Nonokawa M, Hirayama H, Tsuboi N, Ito T, Hirai M, Yokota M, Saito H. Evaluation of left ventricular function using electrocardiographically gated myocardial SPECT with 123I-labeled fatty acid analog. J Nucl Med 2001; 42: 1747–56.
- Lee TH, Hamilton MA, Stevenson LW, Moriguchi JD, Fonarow GC, Child JS, Laks H, Walden JA. Impact of left ventricular cavity size on survival in advance heart failure. Am J Cardiol 1993; 72: 672–6.
- Kjoller-Hansen L, Steffensen R, Grande P. Beneficial effects of ramipril on left ventricular end-diastolic and end-systolic volume indexes after uncomplicated invasive revasculariza-tion are associated with a reduction in cardiac events in patients with moderately impaired left ventricular function and no clinical heart failure. J Am Coll Cardiol 2001; 37: 1214–20.
- Sharir T, Bacher-Stier C, Dhar S, Lewin H, Miranda R, Friedman J, Germano G, Berman D. Identification of severe and extensive coronary artery disease by post-exercise regional wall motion abnormalities in Tc-99m Sestamibi single-photon emission computed tomography. Am J Cardiol 2000; 86: 1171–5.
- Rahimtoola SH. Hibernating myocardium has reduced blood flow at rest that increases with low-dose dobutamine. Circulation 1996; 94: 3055–61.
- Gallagher KP, Matsuzaki M, Koziol JA, Kemper WS, Ross Hr. Regional myocardial perfusion and wall thickening during ischemia in conscious dogs. Am J Physiol 1984; 247: H727–H738.
- Bestetti A, Triulzi A, Di Leo C, Tagliabue L, Del Sole A, Lomuscio A, Vergani D, Tarricone D, Marano L, Fiorentini C, Tarolo GL. Myocardial scintigraphy by the gated SPECT method in coronary artery disease patients with post-ischemic stunning. G Ital Cardiol 1999; 29: 143–8.
![A worldwide pioneer in biotechnology.]({"type":"image" , "src" : "/sda/112403/JournalAd-Amgen-MPU.png"})
![Novartis. Your partner in Heart Failure & Atherosclerosis >>]({"type":"image" , "src" : "/sda/112381/JournalAd-TACD-Novartis-Skyscraper.jpg"})